Literature DB >> 12493277

Management of acute optic neuritis.

S J Hickman1, C M Dalton, D H Miller, G T Plant.   

Abstract

Optic neuritis is a common condition that causes reversible loss of vision. It can be clinically isolated or can arise as one of the manifestations of multiple sclerosis. Occasional cases are due to other causes, and in these instances management can differ radically. The treatment of optic neuritis has been investigated in several trials, the results of which have shown that corticosteroids speed up the recovery of vision without affecting the final visual outcome. Other aspects of management, however, are controversial, and there is uncertainty about when to investigate and when to treat the condition. Here we review the diagnostic features of optic neuritis, its differential diagnosis, and give practical guidance about management of patients. The condition's association with multiple sclerosis will be considered in the light of studies that define the risk for development of multiple sclerosis and with respect to results of trials of disease-modifying drugs in these individuals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12493277     DOI: 10.1016/s0140-6736(02)11919-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  60 in total

1.  CSF abnormalities can be predicted by VEP and MRI pathology in the examination of optic neuritis.

Authors:  Henrik Horwitz; Matilda Degn; Signe Modvig; Henrik B W Larsson; Benedikte Wanscher; Jette L Frederiksen
Journal:  J Neurol       Date:  2012-06-06       Impact factor: 4.849

2.  Ophthaproblem. Optic neuritis.

Authors:  Jason Blair; Sanjay Sharma
Journal:  Can Fam Physician       Date:  2003-10       Impact factor: 3.275

3.  Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis.

Authors:  Stephanie B Syc; Shiv Saidha; Scott D Newsome; John N Ratchford; Michael Levy; E'tona Ford; Ciprian M Crainiceanu; Mary K Durbin; Jonathan D Oakley; Scott A Meyer; Elliot M Frohman; Peter A Calabresi
Journal:  Brain       Date:  2011-10-17       Impact factor: 13.501

Review 4.  Loss of vision: imaging the visual pathways.

Authors:  H R Jäger
Journal:  Eur Radiol       Date:  2005-01-26       Impact factor: 5.315

Review 5.  Isolated, relapsing and progressive demyelinating diseases of the central nervous system.

Authors:  Axel Petzold
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

Review 6.  Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported.

Authors:  Axel Petzold; Gordon T Plant
Journal:  J Neurol       Date:  2013-05-23       Impact factor: 4.849

7.  Dissecting structure-function interactions in acute optic neuritis to investigate neuroplasticity.

Authors:  Thomas Jenkins; Olga Ciccarelli; Ahmed Toosy; Katherine Miszkiel; Claudia Wheeler-Kingshott; Daniel Altmann; Laura Mancini; Steve Jones; Gordon Plant; David Miller; Alan Thompson
Journal:  Hum Brain Mapp       Date:  2010-02       Impact factor: 5.038

8.  Management of optic neuritis.

Authors:  Vimla Menon; Rohit Saxena; Ruby Misra; Swati Phuljhele
Journal:  Indian J Ophthalmol       Date:  2011 Mar-Apr       Impact factor: 1.848

9.  New developments in the treatment of optic neuritis.

Authors:  Thomas M Jenkins; Ahmed T Toosy
Journal:  Eye Brain       Date:  2010-06-17

10.  Delayed onset of experimental autoimmune encephalomyelitis in Olig1 deficient mice.

Authors:  Xiaoli Guo; Chikako Harada; Kazuhiko Namekata; Yoshinori Mitamura; Hiroshi Yoshida; Yoh Matsumoto; Takayuki Harada
Journal:  PLoS One       Date:  2010-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.